Market Cap 37.05B
Revenue (ttm) 226.83B
Net Income (ttm) 852.00M
EPS (ttm) N/A
PE Ratio 19.74
Forward PE 17.15
Profit Margin 0.38%
Debt to Equity Ratio -4.05
Volume 1,592,800
Avg Vol 2,030,656
Day's Range N/A - N/A
Shares Out 238.68M
Stochastic %K 49%
Beta 0.68
Analysts Strong Sell
Price Target $180.33

Company Profile

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, special...

Industry: Medical Distribution
Sector: Healthcare
Phone: 614 757 5000
Address:
7000 Cardinal Place, Dublin, United States
Osubuckeye134
Osubuckeye134 Jul. 31 at 6:44 PM
$CAH, $MCK, $COR it has to be understood, how big of an impact a pharma price reduction has on the big 3 distributors. The main drivers for revenue are: distribution fees & cash discounts, these are calculated as a percentage of revenue. Therefore if a drug is $1,000, lets just say they would normally make say $50. If the gov't pushes $LLY and others to reduce price, and the distributors now pay $500 for the same drug, they will then make $25. Same number of packages shipped, same number of invoices due from customers, same number of customer service calls...just a lower base of revenue. It's devastating to the business model, one that assumes inflation, not massive deflation overnight.
0 · Reply
rbhave63
rbhave63 Jul. 21 at 11:35 PM
$CAH RSI(25) on daily level crossed below 52 chances are it would go bearish for the next week just based on the technical indicators
0 · Reply
JarvisFlow
JarvisFlow Jul. 18 at 9:30 PM
Citigroup has adjusted their stance on Cardinal Health ( $CAH ), setting the rating to Neutral with a target price of 130 → 140.
0 · Reply
JarvisFlow
JarvisFlow Jul. 18 at 8:59 PM
Citigroup has updated their rating for Cardinal Health ( $CAH ) to Neutral with a price target of 130.
0 · Reply
JasonCO
JasonCO Jul. 17 at 11:59 AM
$CAH Let’s see how far this gets gashed. Usually doesnt waste much time to dump
1 · Reply
JarvisFlow
JarvisFlow Jul. 16 at 1:00 PM
Morgan Stanley updates rating for Cardinal Health ( $CAH ) to Overweight, target set at 181 → 190.
0 · Reply
TradeInYourJob
TradeInYourJob Jul. 13 at 8:16 PM
$CAH overall bullish chart and bullish context, but a sell signal triggered on the weekly timeframe Channel Commodity Index. Has led to corrections and consolidations in the past. Might not hurt to hedge.
0 · Reply
11thestate
11thestate Jul. 11 at 5:59 AM
For all $CAH investors — you might be surprised, but we have good news. There’s actually a way to recover your losses. You won’t want to miss it. Go check it out now. #CardinalHealth #CAH ➡️ https://11th.com/cases/cardinal-health-investors-settlement
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 8 at 3:19 PM
Cardinal Health ($CAH) stands to benefit from the fluorine-18 market's projected 4.7% CAGR through 2031. As a key player in nuclear medicine distribution with improving margins (0.92% net margin in Q1) and $227B annual revenue, this growth aligns perfectly with their specialty pharmaceuticals segment. Bullish on healthcare's defensive play with radiopharma tailwinds. https://www.prnewswire.com/news-releases/fluorine-18-market-size-projected-to-usd-2-54-billion-by-2031-with-4-7-cagr-experiences-growth-with-rising-prevalence-of-cancer--the-insight-partners-302500201.html
0 · Reply
Okadarlan
Okadarlan Jul. 6 at 8:25 PM
$CAH Its funny how it goes up 1 straight line.
0 · Reply
Latest News on CAH
Best Dividend Aristocrats For July 2025

Jun 29, 2025, 7:19 AM EDT - 4 weeks ago

Best Dividend Aristocrats For July 2025

ABBV ABT ADM ADP AFL ALB AMCR


CAH CFO on Pharmaceutical Distributor's Outlook

Jun 12, 2025, 7:30 PM EDT - 7 weeks ago

CAH CFO on Pharmaceutical Distributor's Outlook


Cardinal Health raises annual profit target

Jun 12, 2025, 7:31 AM EDT - 7 weeks ago

Cardinal Health raises annual profit target


Cramer's Stop Trading: Cardinal Health

Jun 10, 2025, 10:24 AM EDT - 7 weeks ago

Cramer's Stop Trading: Cardinal Health


Best Dividend Aristocrats For June 2025

May 27, 2025, 10:15 PM EDT - 2 months ago

Best Dividend Aristocrats For June 2025

ABBV ABT ADM ADP AFL ALB AMCR


63 Top Dividend Growth Stocks For May 2025

May 8, 2025, 11:00 AM EDT - 3 months ago

63 Top Dividend Growth Stocks For May 2025

ACN ADP AEP CVX LRCX PEP WMT


Cardinal Health Board of Directors Approves Quarterly Dividend

May 5, 2025, 5:30 PM EDT - 3 months ago

Cardinal Health Board of Directors Approves Quarterly Dividend


Cardinal Health, Inc. (CAH) Q3 2025 Earnings Call Transcript

May 1, 2025, 11:48 AM EDT - 3 months ago

Cardinal Health, Inc. (CAH) Q3 2025 Earnings Call Transcript


Best Dividend Aristocrats For May 2025

Apr 29, 2025, 8:07 PM EDT - 3 months ago

Best Dividend Aristocrats For May 2025

ABBV ABT ADM ADP AFL ALB AMCR


ESG Still Matters. 3 Defensive Stocks That Make the Grade.

Apr 10, 2025, 12:32 PM EDT - 4 months ago

ESG Still Matters. 3 Defensive Stocks That Make the Grade.

ATO GIS


Best Dividend Aristocrats For April 2025

Mar 31, 2025, 4:07 PM EDT - 4 months ago

Best Dividend Aristocrats For April 2025

ABBV ABT ADM BDX BEN BRO CL


Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 1:32 PM EST - 6 months ago

Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript


Cardinal Health Q1 Earnings: Margins Signal More Upside

Nov 4, 2024, 3:24 PM EST - 9 months ago

Cardinal Health Q1 Earnings: Margins Signal More Upside


Cardinal Health, Inc. (CAH) Q1 2025 Earnings Call Transcript

Nov 1, 2024, 12:07 PM EDT - 9 months ago

Cardinal Health, Inc. (CAH) Q1 2025 Earnings Call Transcript


Osubuckeye134
Osubuckeye134 Jul. 31 at 6:44 PM
$CAH, $MCK, $COR it has to be understood, how big of an impact a pharma price reduction has on the big 3 distributors. The main drivers for revenue are: distribution fees & cash discounts, these are calculated as a percentage of revenue. Therefore if a drug is $1,000, lets just say they would normally make say $50. If the gov't pushes $LLY and others to reduce price, and the distributors now pay $500 for the same drug, they will then make $25. Same number of packages shipped, same number of invoices due from customers, same number of customer service calls...just a lower base of revenue. It's devastating to the business model, one that assumes inflation, not massive deflation overnight.
0 · Reply
rbhave63
rbhave63 Jul. 21 at 11:35 PM
$CAH RSI(25) on daily level crossed below 52 chances are it would go bearish for the next week just based on the technical indicators
0 · Reply
JarvisFlow
JarvisFlow Jul. 18 at 9:30 PM
Citigroup has adjusted their stance on Cardinal Health ( $CAH ), setting the rating to Neutral with a target price of 130 → 140.
0 · Reply
JarvisFlow
JarvisFlow Jul. 18 at 8:59 PM
Citigroup has updated their rating for Cardinal Health ( $CAH ) to Neutral with a price target of 130.
0 · Reply
JasonCO
JasonCO Jul. 17 at 11:59 AM
$CAH Let’s see how far this gets gashed. Usually doesnt waste much time to dump
1 · Reply
JarvisFlow
JarvisFlow Jul. 16 at 1:00 PM
Morgan Stanley updates rating for Cardinal Health ( $CAH ) to Overweight, target set at 181 → 190.
0 · Reply
TradeInYourJob
TradeInYourJob Jul. 13 at 8:16 PM
$CAH overall bullish chart and bullish context, but a sell signal triggered on the weekly timeframe Channel Commodity Index. Has led to corrections and consolidations in the past. Might not hurt to hedge.
0 · Reply
11thestate
11thestate Jul. 11 at 5:59 AM
For all $CAH investors — you might be surprised, but we have good news. There’s actually a way to recover your losses. You won’t want to miss it. Go check it out now. #CardinalHealth #CAH ➡️ https://11th.com/cases/cardinal-health-investors-settlement
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 8 at 3:19 PM
Cardinal Health ($CAH) stands to benefit from the fluorine-18 market's projected 4.7% CAGR through 2031. As a key player in nuclear medicine distribution with improving margins (0.92% net margin in Q1) and $227B annual revenue, this growth aligns perfectly with their specialty pharmaceuticals segment. Bullish on healthcare's defensive play with radiopharma tailwinds. https://www.prnewswire.com/news-releases/fluorine-18-market-size-projected-to-usd-2-54-billion-by-2031-with-4-7-cagr-experiences-growth-with-rising-prevalence-of-cancer--the-insight-partners-302500201.html
0 · Reply
Okadarlan
Okadarlan Jul. 6 at 8:25 PM
$CAH Its funny how it goes up 1 straight line.
0 · Reply
JarvisFlow
JarvisFlow Jul. 3 at 11:00 AM
Citigroup updates rating for Cardinal Health ( $CAH ) to Neutral, target set at 140 → 157.
0 · Reply
11thestate
11thestate Jul. 2 at 11:23 AM
#CardinalHealth agreed to a $109M settlement with $CAH investors over claims it misled them about the integration of Cordis, inventory management, and accounting for obsolete inventory. If you bought $CAH between March 2, 2015, and May 2, 2018, you can file a claim for payment here: https://11th.com/cases/cardinal-health-investors-settlement
0 · Reply
11thestate
11thestate Jun. 24 at 10:41 AM
$CAH investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #CardinalHealth $CAH https://11th.com/cases/cardinal-health-investors-settlement
0 · Reply
OptionSamurai
OptionSamurai Jun. 23 at 3:33 PM
$CAH appears in our Dividend Capture scan. The idea is to buy shares + sell call to enjoy premium and the dividend. ☑ The Fundamental score is 9 ☑ Growth score is 9 ☑ Dividend date 01-Jul-25 ☑ IV Percentile is 22.2% Covered Call 165.0, 18-Jul-25: 📈 An annualized return of 26.0% 📉 The breakeven point is 1.8% 👉 See more results & customize here: https://bit.ly/3lR1xIP
0 · Reply
DanaBlack
DanaBlack Jun. 20 at 3:53 PM
$OSCR look at $UNH and $HCA. This is where it’s going. $CAH is just a medical supply company and look where it’s at!
0 · Reply
HahaYouSUCK
HahaYouSUCK Jun. 20 at 1:59 PM
$OSCR should get bought out by $CAH $HIMS $UNH just do it no regrets
0 · Reply
DanaBlack
DanaBlack Jun. 20 at 1:42 PM
$OSCR won’t be selling until it’s around $CAH price
0 · Reply
abubnic
abubnic Jun. 17 at 4:32 PM
$CAH Long position for me. Up +227%. Pays a nice dividend. Next ex-div date: July 1st. Last week, the drug distributor raised its fiscal 2025 earnings outlook and offered a preliminary bottom-line view above market estimates at the midpoint for the following year. "Our business and our industry are quite resilient," Chief Executive Jason Hollar said during Thursday's investor day, according to a FactSet transcript.
0 · Reply
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
JarvisFlow
JarvisFlow Jun. 13 at 5:28 PM
Morgan Stanley has adjusted their stance on Cardinal Health ( $CAH ), setting the rating to Overweight with a target price of 166 → 181.
0 · Reply
patriciamur220
patriciamur220 Jun. 13 at 12:18 PM
$CAH GreetEat Corporation (OTC: GEAT) 🔥 + Stripe = seamless voucher 💳 Imagine: click-to-order food inside your Zoom, paid via Stripe ✅ Microcap. Patent filed. 10X potential. From $0.03 ➡️ $0.135 in a day = +350% 🚀 This is pre-Stripe PR. BTFD or regret later.
0 · Reply